**Core Concept**
Coal tar is a known carcinogen that has been associated with various types of cancer due to its mutagenic and genotoxic properties. Exposure to coal tar can lead to the development of skin, bladder, and lung cancers, primarily through its metabolites, such as polycyclic aromatic hydrocarbons (PAHs). The carcinogenic effects of coal tar are well-documented and have been linked to occupational exposure in industries like coal mining, coking, and roofing.

**Why the Correct Answer is Right**
Leukemia, particularly acute myeloid leukemia (AML), has not been directly associated with coal tar exposure. In contrast, skin cancer (B) is a well-established consequence of coal tar exposure, primarily due to the formation of PAH-DNA adducts that lead to genetic mutations. Bladder cancer (A) is also linked to coal tar exposure, as its metabolites are excreted in the urine and can cause DNA damage in bladder epithelial cells. Lung cancer (C) is another known risk, resulting from the inhalation of coal tar particles that can lead to chronic inflammation and genetic mutations in lung tissue.

**Why Each Wrong Option is Incorrect**
**Option A:** Bladder cancer is associated with coal tar exposure, as its metabolites can cause DNA damage in bladder epithelial cells, leading to cancer development.
**Option B:** Skin cancer is a well-established consequence of coal tar exposure, primarily due to the formation of PAH-DNA adducts that lead to genetic mutations.
**Option C:** Lung cancer is also linked to coal tar exposure, resulting from the inhalation of coal tar particles that can lead to chronic inflammation and genetic mutations in lung tissue.

**Clinical Pearl / High-Yield Fact**
Coal tar exposure is a known occupational hazard, and its carcinogenic effects can be mitigated by implementing proper safety protocols, including the use of protective gear and regular monitoring of exposure levels. Additionally, workers in high-risk industries should undergo regular health check-ups to detect any potential health issues early.

**✓ Correct Answer: D. Leukemia**